Landiolol, an ultra-short-acting β?-blocker, more effectively terminates atrial fibrillation than diltiazem after open heart surgery: prospective, multicenter, randomized, open-label study (JL-KNIGHT study).

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1097-1101
Number of pages5
JournalCirc J
Volume76
Publication statusPublished - 2012

Cite this

@article{0298237c6ceb4699b904da15fded35e3,
title = "Landiolol, an ultra-short-acting β?-blocker, more effectively terminates atrial fibrillation than diltiazem after open heart surgery: prospective, multicenter, randomized, open-label study (JL-KNIGHT study).",
author = "Tatsuo Iwasaki",
year = "2012",
language = "English",
volume = "76",
pages = "1097--1101",
journal = "Circ J",

}

TY - JOUR

T1 - Landiolol, an ultra-short-acting β?-blocker, more effectively terminates atrial fibrillation than diltiazem after open heart surgery: prospective, multicenter, randomized, open-label study (JL-KNIGHT study).

AU - Iwasaki, Tatsuo

PY - 2012

Y1 - 2012

M3 - Article

VL - 76

SP - 1097

EP - 1101

JO - Circ J

JF - Circ J

ER -